BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
535 results:

  • 1. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
    BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
    Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
    Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Leukocytoclastic Vasculitis Localized to the Uterine Cervix.
    Roble JG; Ligon SE; Langan KL
    Hawaii J Health Soc Welf; 2024 Mar; 83(3):81-84. PubMed ID: 38456159
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic value of insulin resistance in patients with female reproductive system malignancies: A multicenter cohort study.
    Liu XY; Zhang Q; Zhang X; Ge YZ; Ruan GT; Xie HL; Liu T; Song MM; Deng L; Shi HP
    Immun Inflamm Dis; 2023 Dec; 11(12):e1107. PubMed ID: 38156375
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
    Al-Oseely S; Abdul Manaf R; Ismail S
    PLoS One; 2023; 18(12):e0290152. PubMed ID: 38100481
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer.
    Choi N; Kang YJ; Cho J; Oh D; Jeong J; Jeong HS
    Clin Exp Metastasis; 2024 Feb; 41(1):33-43. PubMed ID: 38079016
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.
    Li K; Chen J; Hu Y; Wang YZ; Shen Y; Chen G; Peng W; Fang Z; Xia B; Chen X; Song K; Wang Y; Zou D; Wang YC; Han Y; Feng X; Yuan J; Guo S; Meng X; Feng C; Chen Y; Yang J; Fan J; Wang J; Ai J; Ma D; Sun C
    Lancet Oncol; 2024 Jan; 25(1):76-85. PubMed ID: 38048802
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
    Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
    Mwaliko E; Itsura P; Keter A; De Bacquer D; Buziba N; Bastiaens H; Jackie A; Obala A; Naanyu V; Gichangi P; Temmerman M
    BMC Cancer; 2023 Nov; 23(1):1104. PubMed ID: 37957644
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study.
    Isaka T; Adachi H; Murakami K; Miura J; Kikunishi N; Shigeta N; Kudo Y; Miyata Y; Okada M; Ikeda N; Ito H
    BMC Cancer; 2023 Nov; 23(1):1064. PubMed ID: 37926846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Human Papillomavirus Detectability and cervical cancer prognosis: A Systematic Review and Meta-analysis.
    Volesky-Avellaneda KD; Laurie C; Tsyruk-Romano O; El-Zein M; Franco EL
    Obstet Gynecol; 2023 Nov; 142(5):1055-1067. PubMed ID: 37856917
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Correlation Between Persistent HPV Infection and Vaginal Microecological Imbalance After Treatment of cervical High-Grade Squamous Intraepithelial Lesion.
    Zhang S; Cao Y; Hu Y; Li G; Lan H
    Altern Ther Health Med; 2024 Jan; 30(1):414-418. PubMed ID: 37820668
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. miR-203a-A multifaceted regulator modulating cancer hallmarks and therapy response.
    Biswal P; Lalruatfela A; Behera SK; Biswal S; Mallick B
    IUBMB Life; 2024 Mar; 76(3):108-124. PubMed ID: 37792370
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases.
    Li J; Wang Y; Huo L; Huang X; Shi L; Huang L; Chen K; Cao X
    Radiat Oncol; 2023 Sep; 18(1):159. PubMed ID: 37752606
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
    Enomoto T; Okamoto A; Kim JH; Lai CH; Wu X; Kim YM
    J Gynecol Oncol; 2023 Sep; 34(5):e86. PubMed ID: 37593814
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trial.
    Wu X; Yu H; Bai Y; Hou Y; Lou W; Wang X; Zhu T; Zhang Y; Hu W; Xue X; Zhu Z; Xiang L; Li J; Fang X; Gao S; Feng H; Diao W; Zhang H; Du M; Yan W; Qiu L; Feng H; Zhu S; Du Y; Jiang H
    Trials; 2023 Aug; 24(1):542. PubMed ID: 37592299
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal cancer prognosis.
    Fujita Y; Fukuda Y; Sanuki F; Irei I; Monobe Y; Uno M; Akisada T; Shimoya K; Hara H; Moriya T
    Head Neck Pathol; 2023 Sep; 17(3):658-672. PubMed ID: 37486532
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.